ALKS Stock | News | Quote | Stock Forum | Saturday, January 11,
Post# of 250601
Posted On: 01/11/2014 12:24:43 PM
$ALKS Alkermes plc ALKS Company Overview
Stock Message Board http://investorshangout.com/search?q=ALKS&...mp;yt1=Go!
Last Updated: Saturday, January 11, 2014 12:24:33 PM
Alkermes plc ALKS Current Price and Quotes
Last Price 45.13
Previous Close
43.05
Open
43.07
Daily Range
45.17 - 42.77
52wk Range
43.65 - 19.77
Volume
1,170,095
Dividend
N/A
Average Vol (3m)
895,342
Yield
N/A
Alkermes plc ALKS
Company Information
88 Sidney Street
Cambridge, MA 02139
Phone: (617) 494-0171
Alkermes plc ALKS
Not Available
Alkermes plc ALKS
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000874663
Fiscal Year End 3/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: PA, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Formerly=Alkermes, Inc. until 9-2011
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Alkermes plc ALKS
ALKS Security Details
Share Structure
Market Value1 $6,172,086,300 a/o Jan 10, 2014
Shares Outstanding 136,762,382 a/o Oct 28, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.01
Shareholders
Shareholders of Record 352 a/o May 30, 2008
Security Notes
New Issue=7-91 1,750,000 shs at $10 by Robertson, Stephens & Co. et al.
Latest Addt'l Issue=9-95 2,000,000 shs at $7 by Robertson, Stephens & Co. et al.
Capital Change=shs increased by 2 for 1 split. Ex-date=05/15/2000. Rec date=04/28/2000. Pay date=05/12/2000.
Short Selling Data
Short Interest 5,240,252 (-9.68%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
Computershare Investor Services LLC
Alkermes plc ALKS Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue 575,548 389,977 186,640
Cost of Revenue 170,466 127,578 52,185
Gross Profit 405,082 262,399 134,455
Operating Expenses
Research and Development 140,013 141,893 97,239
Sales, General and Admin. 125,758 137,632 82,847
Non-Recurring Items 15,646 45,800 -
Other 41,852 25,355 -
Operating Income 81,813 (88,281) (45,631)
Income From Continuing Operations
Add'l Income/Expense Items 2,622 2,000 2,438
Earnings Before Interest and Tax 84,435 (86,281) (43,193)
Interest Expense 48,994 28,111 3,298
Earnings Before Tax 35,441 (114,392) (46,491)
Income Tax 10,458 (714) (951)
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations 24,983 (113,678) (45,540)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 24,983 (113,678) (45,540)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 24,983 (113,678) (45,540)
Alkermes plc ALKS Recent News
Jan 8, 2014 The Zacks Analyst Blog Highlights:FedEx, Alkermes, Biogen Idec, Perrigo and BioMarin Pharmaceutical
Jan 8, 2014 Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD
Jan 8, 2014 Alkermes Announces Advances With Its Late-Stage CNS Pipeline
Jan 7, 2014 Alkermes' Corporate Presentation to be Webcast at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2014 Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis
Dec 18, 2013 FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira
Dec 10, 2013 Morning Research Covering Healthcare Sector: Hospira, Alkermes, Theravance, and Celsion
Dec 9, 2013 Alkermes Presents Data on Two Late-Stage Clinical Candidates, Aripiprazole Lauroxil and ALKS 5461, at 52nd Annual ACNP Meeting
Dec 6, 2013 Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's
Nov 22, 2013 Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes
12next >
ALKS Alkermes plc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ALKS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ALKS/quote
Stock Chart http://www.otcmarkets.com/stock/ALKS/chart
Company Info http://www.otcmarkets.com/stock/ALKS/company-info
Recent News http://www.otcmarkets.com/stock/ALKS/news
Financials http://www.otcmarkets.com/stock/ALKS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ALKS/filings
Short Sales http://www.otcmarkets.com/stock/ALKS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ALKS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ALKS/research
Summary http://finance.yahoo.com/q?s=ALKS
Historical Prices http://finance.yahoo.com/q/hp?s=ALKS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ALKS
Basic Chart http://finance.yahoo.com/q/bc?s=ALKS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ALKS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ALKS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ALKS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ALKS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ALKS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ALKS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ALKS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ALKS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ALKS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ALKS
Balance Sheet http://finance.yahoo.com/q/bs?s=ALKS
Cash Flow http://finance.yahoo.com/q/cf?s=ALKS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ALKS
Market Watch http://www.marketwatch.com/investing/stock/ALKS
Bloomberg http://www.bloomberg.com/quote/ALKS:US
Morningstar http://quotes.morningstar.com/stock/s?t=ALKS
Bussinessweek http://investing.businessweek.com/research/st...icker=ALKS
Barchart http://www.barchart.com/quotes/stocks/ALKS
OTC Short Report http://otcshortreport.com/index.php?index=ALKS
Investopedia http://www.investopedia.com/markets/stocks/ALKS/?wa=0
Stock Message Board http://investorshangout.com/search?q=ALKS&...mp;yt1=Go!
Last Updated: Saturday, January 11, 2014 12:24:33 PM
Alkermes plc ALKS Current Price and Quotes
Last Price 45.13
Previous Close
43.05
Open
43.07
Daily Range
45.17 - 42.77
52wk Range
43.65 - 19.77
Volume
1,170,095
Dividend
N/A
Average Vol (3m)
895,342
Yield
N/A
Alkermes plc ALKS
Company Information
88 Sidney Street
Cambridge, MA 02139
Phone: (617) 494-0171
Alkermes plc ALKS
Not Available
Alkermes plc ALKS
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000874663
Fiscal Year End 3/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: PA, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Formerly=Alkermes, Inc. until 9-2011
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Alkermes plc ALKS
ALKS Security Details
Share Structure
Market Value1 $6,172,086,300 a/o Jan 10, 2014
Shares Outstanding 136,762,382 a/o Oct 28, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.01
Shareholders
Shareholders of Record 352 a/o May 30, 2008
Security Notes
New Issue=7-91 1,750,000 shs at $10 by Robertson, Stephens & Co. et al.
Latest Addt'l Issue=9-95 2,000,000 shs at $7 by Robertson, Stephens & Co. et al.
Capital Change=shs increased by 2 for 1 split. Ex-date=05/15/2000. Rec date=04/28/2000. Pay date=05/12/2000.
Short Selling Data
Short Interest 5,240,252 (-9.68%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
Computershare Investor Services LLC
Alkermes plc ALKS Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue 575,548 389,977 186,640
Cost of Revenue 170,466 127,578 52,185
Gross Profit 405,082 262,399 134,455
Operating Expenses
Research and Development 140,013 141,893 97,239
Sales, General and Admin. 125,758 137,632 82,847
Non-Recurring Items 15,646 45,800 -
Other 41,852 25,355 -
Operating Income 81,813 (88,281) (45,631)
Income From Continuing Operations
Add'l Income/Expense Items 2,622 2,000 2,438
Earnings Before Interest and Tax 84,435 (86,281) (43,193)
Interest Expense 48,994 28,111 3,298
Earnings Before Tax 35,441 (114,392) (46,491)
Income Tax 10,458 (714) (951)
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations 24,983 (113,678) (45,540)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 24,983 (113,678) (45,540)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 24,983 (113,678) (45,540)
Alkermes plc ALKS Recent News
Jan 8, 2014 The Zacks Analyst Blog Highlights:FedEx, Alkermes, Biogen Idec, Perrigo and BioMarin Pharmaceutical
Jan 8, 2014 Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD
Jan 8, 2014 Alkermes Announces Advances With Its Late-Stage CNS Pipeline
Jan 7, 2014 Alkermes' Corporate Presentation to be Webcast at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2014 Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis
Dec 18, 2013 FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira
Dec 10, 2013 Morning Research Covering Healthcare Sector: Hospira, Alkermes, Theravance, and Celsion
Dec 9, 2013 Alkermes Presents Data on Two Late-Stage Clinical Candidates, Aripiprazole Lauroxil and ALKS 5461, at 52nd Annual ACNP Meeting
Dec 6, 2013 Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's
Nov 22, 2013 Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes
12next >
ALKS Alkermes plc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ALKS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ALKS/quote
Stock Chart http://www.otcmarkets.com/stock/ALKS/chart
Company Info http://www.otcmarkets.com/stock/ALKS/company-info
Recent News http://www.otcmarkets.com/stock/ALKS/news
Financials http://www.otcmarkets.com/stock/ALKS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ALKS/filings
Short Sales http://www.otcmarkets.com/stock/ALKS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ALKS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ALKS/research
Summary http://finance.yahoo.com/q?s=ALKS
Historical Prices http://finance.yahoo.com/q/hp?s=ALKS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ALKS
Basic Chart http://finance.yahoo.com/q/bc?s=ALKS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ALKS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ALKS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ALKS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ALKS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ALKS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ALKS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ALKS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ALKS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ALKS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ALKS
Balance Sheet http://finance.yahoo.com/q/bs?s=ALKS
Cash Flow http://finance.yahoo.com/q/cf?s=ALKS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ALKS
Market Watch http://www.marketwatch.com/investing/stock/ALKS
Bloomberg http://www.bloomberg.com/quote/ALKS:US
Morningstar http://quotes.morningstar.com/stock/s?t=ALKS
Bussinessweek http://investing.businessweek.com/research/st...icker=ALKS
Barchart http://www.barchart.com/quotes/stocks/ALKS
OTC Short Report http://otcshortreport.com/index.php?index=ALKS
Investopedia http://www.investopedia.com/markets/stocks/ALKS/?wa=0
(0)
(0)Scroll down for more posts ▼